Loading…
The automated radiosynthesis of [ 18F]FP-TZTP
[ 18F]FP-TZTP (3-(3-(3-[ 18F]fluoropropylthio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine) is a muscarinic ligand that displays in vivo selectivity for the M2 subtype. We have developed a one-step radiosynthesis of [ 18F]FP-TZTP that can be conducted with an automated synthesis unit....
Saved in:
Published in: | Nuclear medicine and biology 2003, Vol.30 (1), p.73-77 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [
18F]FP-TZTP (3-(3-(3-[
18F]fluoropropylthio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine) is a muscarinic ligand that displays
in vivo selectivity for the M2 subtype. We have developed a one-step radiosynthesis of [
18F]FP-TZTP that can be conducted with an automated synthesis unit. A number of hardware and software modifications to a Nuclear Interface C-11 Methylation System provided the equipment for the automated radiosynthesis. The manual synthesis produced [
18F]FP-TZTP in a radiochemical yield of 23.4% ± 4.3% (EOS, n = 69) with a specific activity of 4377 ± 2011 mCi/μmol (EOB, n = 100). The automated synthesis unit provided the product in a radiochemical yield of 18.8% ± 2.4% (EOS, n = 25) with a specific activity of 4112 ± 2572 mCi/μmol (EOB, n = 25). |
---|---|
ISSN: | 0969-8051 1872-9614 |
DOI: | 10.1016/S0969-8051(02)00354-2 |